Do 2-month-old infants have a sense of taste similar to adults, specifically in detecting bitterness, when given Tuberculosis (TB) tablets or other syrups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Taste Perception in 2-Month-Old Infants

Yes, 2-month-old infants can taste bitterness and have a well-developed sense of taste that includes aversion to bitter flavors, making them likely to reject bitter-tasting TB medications and syrups. 1

Infant Taste Development at 2 Months

Infants are born with remarkably sensitive taste perception—they actually have more taste buds (approximately 10,000) than adults, which are more widely distributed throughout the oral cavity. 2 This heightened sensitivity means that 2-month-old babies experience tastes more intensely than older children or adults.

Specific Taste Responses in Young Infants

  • Sweet taste: Infants show an innate preference for sweetness from birth, which is evolutionarily programmed to attract them to energy-rich foods like breast milk. 1, 3

  • Bitter taste: Aversions to bitterness appear from a very early age and are present at 2 months. 1 Bitter flavors are likely to significantly decrease palatability and cause rejection of medications. 1

  • Salty taste: At 2 months, saltiness may be aversive or neutral to infants, with adult patterns of salt preference not developing until approximately age 2. 1

Practical Implications for TB Medication Administration

The bitter taste of TB medications will be detected and likely rejected by 2-month-old infants, requiring specific formulation strategies. 1

According to European Respiratory Society/WHO/IUATLD guidelines, TB drugs for young infants can be administered via syrup formulations (for isoniazid and rifampin), which may help mask bitterness, or through crushed tablets mixed with appropriate vehicles. 4 However, the guidelines acknowledge that lack of specific pediatric drug formulations can cause delays and interruptions in treatment due to palatability issues. 4

Clinical Strategies

  • Syrup formulations are preferred when available for isoniazid (H) and rifampin (R) in infants, as these may be better tolerated than crushed tablets. 4

  • Crushing tablets may be necessary for some medications like pyrazinamide (Z), which can be administered through a nasogastric tube if oral rejection is severe. 4

  • Adding sweet substances to medications is almost certain to increase palatability given infants' innate sweet preference, though this must be balanced against medication stability and dosing accuracy. 1

Important Caveats

The heightened taste sensitivity in 2-month-old infants means they will experience bitter medications more intensely than adults, potentially leading to feeding difficulties and treatment adherence challenges. 2 Directly observed therapy (DOT) is essential in pediatric TB treatment to ensure medication administration despite taste-related rejection. 4

Salivary protein composition may also influence bitter taste acceptance in young infants, with significant individual variability observed even at 3 months of age. 5 This means some infants may tolerate bitter medications better than others due to biological factors beyond simple taste preference.

References

Research

Sensory development in children: research in taste and olfaction.

Journal of the American Dietetic Association, 1985

Research

The Development of Healthy Eating and Food Pleasure in Infancy.

Nestle Nutrition Institute workshop series, 2023

Research

Taste development and prenatal prevention.

European journal of paediatric dentistry, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.